Corcept Therapeutics CORT Q1 2026 Earnings Severe Earnings Miss Overshadows Operational Developments AVTR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 3 SVM Q1 2026 Earnings Modest EPS Beat Amid Silver Price Volatility EFOI Q4 2024 Earnings Narrowed Loss Amid Continued Strategic Restructuring CC Q1 2026 Earnings Strong EPS Surprise Despite Unreported Revenue SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment